Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

Delve into Roche's strategy, a company originally built on oncology, now reinventing its pipeline in obesity and immunology.

Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

Home to the European Commission (EC), Belgium holds a reputation for life sciences and innovation in Europe. In the port city of Ghent, the Vlaams Instituut voor Biotechnologie (VIB) wants to bridge ...

Despite decades of progress in oncology, the majority of cancer drugs that enter clinical trials never reach the market and the patients who need them most. Late-stage failure remains one of the most ...

What readers will learn: Reduce manual effort through one automated, closed T cell manufacturing workflow, transferred across multiple sites with reproducible outcomes. Strengthen QC readiness through ...

For some biotech companies, a rebrand is the public face of a strategic restructuring after years of pursuing a business model that failed to deliver on its promise. For others, it marks a dramatic ...